Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Phase 2 Completed
17 enrolled
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Phase 2 Completed
35 enrolled
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
Phase 3 Completed
289 enrolled 17 charts
Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer
Phase 3 Completed
Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery
Phase NA Completed
116 enrolled
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Phase 2 Completed
33 enrolled
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Phase 2 Completed
106 enrolled 14 charts
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Phase 3 Completed
350 enrolled
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
Phase 3 Completed
Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
Phase 2 Completed
51 enrolled
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
Phase 2 Completed
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
Phase 2 Completed
76 enrolled
Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Phase 3 Completed
240 enrolled
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
Phase 2 Completed
Chemotherapy in Treating Patients With Sarcoma of the Uterus
Phase 2 Completed
Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
Phase 2 Completed
Quality of Life in Survivors of Gynecologic Cancer
Completed
311 enrolled
Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
Phase 2 Completed
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
Phase 3 Completed
313 enrolled
Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus
Phase 3 Completed
224 enrolled
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
Phase 2 Completed
132 enrolled
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma
Phase 1/2 Completed
91 enrolled
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
Phase 2 Completed
Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
Phase 2 Completed
141 enrolled
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
Phase 3 Completed
340 enrolled
Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer
Phase 3 Completed
214 enrolled
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
Phase 2 Completed
57 enrolled